Q4 2025 Earnings Call March 10, 2026 5:00 AM EDTCompany ParticipantsAlexander Vaughan - CEO, Member of Group Executive Board ...
Earnings call Costain's FY2025 saw adjusted operating profit rise 9.3% to £47.1m despite a 16.4% revenue decline, with margins advancing to 4.5%. The company secured a record £7bn forward work ...
Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsHani Abouhalka - Company ...
We benefited from record gold and silver prices during the quarter, strong production from Antamina and South Arturo, and contributions from Precious Metal assets which were acquired or commenced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results